Roflumilast for asthma: Safety findings from a pooled analysis of ten clinical studies
Conclusions The severity and incidence of AEs reported from this pooled safety analysis confirm that roflumilast is generally well tolerated by patients with asthma. This reflects the general safety profile reported previously in patients with COPD. All studies were funded by Takeda. Trial registration numbers available on ClinicalTrials.gov: NCT00073177, NCT00076076, NCT00163527.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
More News: African Health | Asthma | Chronic Obstructive Pulmonary | Diarrhoea | Drugs & Pharmacology | Gastroenterology | Headache | Migraine | Respiratory Medicine | Study | Weight Loss